EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Accelerated Cardiac Allograft Vasculopathy in an Orthotopic Heart Transplant Recipient with Prior COVID-19

Neil U Parikh, Neal M Dixit iD, Austin B Churchill, Andrea Oliveira-Kowaleski, Ryan P Lau, Gregory A Fishbein iD, Jeffrey J Hsu

American Journal of Case Reports · 2023

DOI: 10.12659/ajcr.937955 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Case Reports, 2023. Verfasst von Neil U Parikh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Heart Transplantation, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Cardiac allograft vasculopathy (CAV) is a post-orthotopic heart transplant (OHT) complication driven by intimal smooth muscle proliferation and immune hyperactivity to donor heart tissue. Accelerated CAV leads to allograft failure within 1 year after receiving a normal angiogram result. Viruses can contribute to CAV development, but CAV after SARS-CoV-2 infection has not been reported to date. CASE REPORT A 48-year-old man, 5 years after OHT for non-ischemic cardiomyopathy, was admitted to the Cardiac Care Unit with 3 days of abdominal pain, dyspnea, and palpitations. His medical history included hyperlipidemia and insulin-dependent diabetes. He was compliant with all medications. Two months prior, he had a mild COVID-19 case. An echocardiogram and coronary angiogram 6 and 9 months prior, respectively, were unremarkable. Right and left heart catheterization demonstrated increased filling pressures, a cardiac index of 1.7 L/ml/m², and diffuse vasculopathy most severe in the LAD artery. Flow could not be restored despite repeated ballooning and intra-catheter adenosine. Empiric ionotropic support, daily high-dose methylprednisolone, and plasmapheresis were started. A few days later, the patient had cardiac arrest requiring venoarterial extracorporeal membranous oxygenation. Given CAV's irreversibility, re-transplantation was considered, but the patient had an episode of large-volume hemoptysis and remained clinically unstable for transplant. The patient died while on palliative care. CONCLUSIONS Our patient developed accelerated CAV 2 months after having COVID-19. While CAV has known associations with certain viruses, its incidence after SARS-CoV-2 infection is unknown. Further research is needed to determine if prior SARS-CoV-2 infection is a risk factor for development of CAV in OHT recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationCOVID-19MaleHumansMiddle AgedSARS-CoV-2Tissue DonorsCoronary AngiographyAllografts

Autor:innen und Institutionen

  • Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, USA.
  • Division of Cardiology, Department of Medicine, UC Davis Medical Center, Sacramento, CA, USA.
  • David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
  • Department of Pathology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
  • Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
  • Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.

ORCID-Profile: Neal M Dixit, Gregory A Fishbein

Zitieren

APA

Parikh, N. U., Dixit, N. M., Churchill, A. B., Oliveira-Kowaleski, A., Lau, R. P., Fishbein, G. A., & Hsu, J. J. (2023). Accelerated Cardiac Allograft Vasculopathy in an Orthotopic Heart Transplant Recipient with Prior COVID-19. American Journal of Case Reports. https://doi.org/10.12659/ajcr.937955

Vancouver

Parikh NU, Dixit NM, Churchill AB, Oliveira-Kowaleski A, Lau RP, Fishbein GA, et al. Accelerated Cardiac Allograft Vasculopathy in an Orthotopic Heart Transplant Recipient with Prior COVID-19. American Journal of Case Reports. 2023. doi:10.12659/ajcr.937955

BibTeX
@article{Parikh2023,
  author = {Parikh, Neil U and Dixit, Neal M and Churchill, Austin B and Oliveira-Kowaleski, Andrea and Lau, Ryan P and Fishbein, Gregory A and Hsu, Jeffrey J},
  title = {Accelerated Cardiac Allograft Vasculopathy in an Orthotopic Heart Transplant Recipient with Prior COVID-19},
  journal = {American Journal of Case Reports},
  year = {2023},
  doi = {10.12659/ajcr.937955}
}
Kostenlos starten →